Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and Safety Of Subcutaneous Administration Of Tabalumab, An Anti-B Cell Activating Factor Monoclonal Antibody, In Rheumatoid Arthritis: Results From a Phase 3 Multicenter, Randomized, Double-Blind Study Genovese, M. C., Silverman, G. J., Emery, P., Gupta, R., Gill, A., Komocsar, W. J., Veenhuizen, M., Xie, L., Berclaz, P., Lee, C. WILEY-BLACKWELL. 2013: S733–S734
View details for Web of Science ID 000325359204191